Ying Han, Howard Raub, and Mikaylah Daugherty, Vaccine Production Technicians, US
Ying Han, Howard Raub, and Mikaylah Daugherty, Vaccine Production Technicians, US
Vaccines
From providing protection against disease at every stage of life to protecting humanity against emerging epidemics, vaccines help create and maintain healthy communities that keep life moving forward.
Remarks for Nuvaxovid at September 2025 ACIP Meeting
At the September 2025 meeting of the Advisory Committee on Immunization Practices, a Sanofi representative shared the following introductory remarks regarding NUVAXOVID™ (COVID-19 Vaccine, Adjuvanted), which will be commercialized by Sanofi beginning this fall.
Influenza
Each year, the flu impacts people around the world. It’s an infectious disease that can be caught and spread by anyone.1 The flu is often more serious than many think – leading to thousands of flu-related complications, hospitalizations, and deaths each year.1
Respiratory Syncytial Virus (RSV)
RSV is highly contagious with 2 out of 3 babies contracting it by age 1. While hospitalization due to RSV is rare, severe RSV can be unpredictable and any infant, even if born full term and healthy, can be hospitalized in their first year.2, 3, 4
Infectious Diseases We Offer Protection Against
Dengue
Diphtheria
Haemophilus influenzae type b infections (Hib)
Hepatitis A
Hepatitis B
Meningococcal meningitis
Pertussis
Poliomyelitis
Rabies
Tetanus
Typhoid fever
Yellow fever
References
- Centers for Disease Control and Prevention. Key Facts About Seasonal Flu Vaccination at https://www.cdc.gov/flu/prevent/keyfacts.htm. Accessed March 2023.
- RSV Symptoms and Diagnosis: American Lung Association. https://www.lung.org/lung-health-diseases/lung-disease-lookup/rsv/symptoms-diagnosis. Accessed May 4, 2022.
- Glezen WP, Taber LH, Frank AL, Kasel JA. Risk of primary infection and reinfection with respiratory syncytial virus. Am J Dis Child. 1986; 140 (6): 543-546.
- Arriola CS, Kim L, Langley G, Anderson EJ, Openo K, Martin AM, et al. Estimated Burden of Community-Onset Respiratory Syncytial Virus-Associated Hospitalizations Among Children Aged <2 Years in the United States, 2014-15. Journal of the Pediatric Infectious Diseases Society. 2020; 9 (5): 587-95.
MAT-US-2023435-v7.0-09/2025